Elekta AB (EKTAY)
6.865
+0.16
(+2.46%)
USD |
OTCM |
Apr 26, 13:58
Elekta Total Assets (Quarterly): 2.953B for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 2.953B |
October 31, 2023 | 2.837B |
July 31, 2023 | 2.928B |
April 30, 2023 | 2.886B |
January 31, 2023 | 2.691B |
October 31, 2022 | 2.483B |
July 31, 2022 | 2.649B |
April 30, 2022 | 2.722B |
January 31, 2022 | 2.927B |
October 31, 2021 | 2.775B |
July 31, 2021 | 2.821B |
April 30, 2021 | 2.969B |
January 31, 2021 | 3.047B |
October 31, 2020 | 2.860B |
July 31, 2020 | 3.087B |
April 30, 2020 | 2.877B |
January 31, 2020 | 2.617B |
October 31, 2019 | 2.617B |
July 31, 2019 | 2.599B |
April 30, 2019 | 2.530B |
January 31, 2019 | 2.512B |
October 31, 2018 | 2.470B |
July 31, 2018 | 2.504B |
April 30, 2018 | 2.741B |
January 31, 2018 | 2.615B |
Date | Value |
---|---|
October 31, 2017 | 2.414B |
July 31, 2017 | 2.425B |
April 30, 2017 | 2.463B |
January 31, 2017 | 2.232B |
October 31, 2016 | 2.228B |
July 31, 2016 | 2.259B |
April 30, 2016 | 2.410B |
January 31, 2016 | 2.302B |
October 31, 2015 | 2.323B |
July 31, 2015 | 2.473B |
April 30, 2015 | 2.540B |
January 31, 2015 | 2.300B |
October 31, 2014 | 2.381B |
July 31, 2014 | 2.549B |
April 30, 2014 | 2.728B |
January 31, 2014 | 2.438B |
October 31, 2013 | 2.410B |
July 31, 2013 | 2.403B |
April 30, 2013 | 2.494B |
January 31, 2013 | 2.317B |
October 31, 2012 | 2.210B |
July 31, 2012 | 2.160B |
April 30, 2012 | 2.268B |
January 31, 2012 | 1.956B |
October 31, 2011 | 1.875B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.483B
Minimum
Oct 2022
3.087B
Maximum
Jul 2020
2.794B
Average
2.829B
Median
Total Assets (Quarterly) Benchmarks
Abliva AB | 8.692M |
Karolinska Development AB | 125.00M |
Calliditas Therapeutics AB | 184.69M |
Oncopeptides AB | 27.02M |
Olink Holding AB | 602.25M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.968B |
Shareholders Equity (Quarterly) | 984.78M |
Debt to Equity Ratio | 0.5719 |
Current Ratio | 1.095 |
Net Debt Paydown Yield | -0.95% |